Dastjerdi
Ahmad Khayer Dastjerdi, Montreal CA
Patent application number | Description | Published |
---|---|---|
20150274587 | METHODS AND SYSTEMS RELATING TO ENHANCING MATERIAL TOUGHNESS - Highly mineralized natural materials often boast unusual combinations of stiffness, strength and toughness currently unmatched by today's engineering materials. Beneficially, according to the embodiments of the invention, these unusual combinations can be introduced into ceramics, glasses, and crystal materials, for example by the introduction of patterns of weaker interfaces with simple or intricate architectures, which channel propagating cracks into toughening configurations. Further, such deliberately-introduced weaker interfaces, such as exploiting three-dimensional arrays of laser-generated microcracks, can deflect and guide larger incoming cracks. Addition of interlocking interfaces and flexible materials provide further energy dissipation and toughening mechanism, by channeling cracks into interlocking configurations and ligament-like pullout mechanisms. Such biomimetic materials, based on carefully architectured interfaces, provide a new pathway to toughening hard and brittle materials. | 10-01-2015 |
Maziar Tavakoli Dastjerdi, Waltham, MA US
Mohammad Dastjerdi, Swampscott, MA US
Patent application number | Description | Published |
---|---|---|
20100183587 | Therapeutic Compositions for Treatment of Corneal Disorders - The invention provides methods and compositions for minimizing, preventing, or treating damage to corneal nerves by administering to a subject with such damage or at risk of exposure to such damage a composition which blocks an activity of an IL-1 cytokine and/or an IL-17 cytokine. | 07-22-2010 |
20100203103 | THERAPEUTIC COMPOSITIONS FOR TREATMENT OF INFLAMMATION OF OCULAR AND ADNEXAL TISSUES - The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also discloses devices for delivering this composition to target tissues. | 08-12-2010 |
Mohammad Dastjerdi, Prairie Village, KS US
Patent application number | Description | Published |
---|---|---|
20120014970 | Therapeutic Compositions for Treatment of Corneal Disorders - The invention provides methods and compositions for minimizing, preventing, or treating damage to corneal nerves by administering to a subject with such damage or at risk of exposure to such damage a composition which blocks an activity of an IL-1 cytokine and/or an IL-17 cytokine. | 01-19-2012 |
20130273065 | Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues - The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also discloses devices for delivering this composition to target tissues. | 10-17-2013 |